Latest Period
Q2 2026
Security Snapshot
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) Institutional Ownership
CUSIP: 15870P307
13F Institutional Holders and Ownership History from Q3 2015 to Q2 2026
Institutions Reporting
27
Shares (Excl. Options)
5,889,252
Price
$6.16
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- CSBR on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 5,889,252
- Total 13F value
- $36,276,009
- Portfolio coverage rank
- 0%
- Share change
- +156,964
- Value change
- +$976,681
- Number of holders
- 27
- Shares outstanding
- 13,838,977
- SEC-reported price per share
- $5.26
- Insider filing price
- $5.26
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share is tracked under CUSIP 15870P307.
- 27 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 24 to 27 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $32,958,797 to $36,276,009.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 27 institutions filings for Q2 2026.
Security key
15870P307
Latest holder period
Q2 2026
13F holders
27
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
CSBR full holder history
CHAMPIONS ONCOLOGY, INC. SEC filings
CHAMPIONS ONCOLOGY, INC. company facts
CHAMPIONS ONCOLOGY, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 15870P307:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
CSBR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 4.4% | $4,633,843 | 608,915 | Tocqueville Asset Management L.P. | 31 Dec 2024 |
As of 30 Jun 2026, 27 institutional investors reported holding 5,889,252 shares of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR). This represents 43% of the company’s total 13,838,977 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
43%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BATTERY MANAGEMENT CORP. | 17% | 2,421,673 | 0% | 4.1% | $14,917,506 |
| NEA Management Company, LLC | 12% | 1,713,720 | 0% | 0.66% | $10,556,515 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.2% | 301,353 | +0.61% | 0% | $1,856,334 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 2.1% | 295,658 | -7.5% | 0.02% | $1,821,253 |
| MORGAN STANLEY | 1.7% | 235,400 | -2.8% | 0% | $1,450,064 |
| BANK OF AMERICA CORP /DE/ | 1.5% | 214,058 | +880% | 0% | $1,318,597 |
| RENAISSANCE TECHNOLOGIES LLC | 1% | 139,039 | -4.5% | 0% | $856,480 |
| BlackRock, Inc. | 0.94% | 129,848 | +4.8% | 0% | $799,864 |
| Mink Brook Asset Management LLC | 0.8% | 111,338 | 0% | 0.3% | $685,842 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.55% | 76,300 | -1.1% | 0% | $470,118 |
| HighTower Advisors, LLC | 0.3% | 41,901 | +19% | 0% | $258,110 |
| VANGUARD FIDUCIARY TRUST CO | 0.24% | 33,239 | +0.75% | 0% | $204,752 |
| NORTHERN TRUST CORP | 0.2% | 27,910 | -39% | 0% | $171,926 |
| STATE STREET CORP | 0.19% | 26,203 | 0% | 0% | $161,410 |
| Bank of New York Mellon Corp | 0.16% | 21,614 | 0% | 0% | $133,142 |
| ACADIAN ASSET MANAGEMENT LLC | 0.15% | 20,523 | -3.8% | 0% | $125,000 |
| CITADEL ADVISORS LLC | 0.13% | 18,295 | 0% | $112,697 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.13% | 18,221 | -0.15% | 0.01% | $112,241 |
| Mesirow Financial Investment Management, Inc. | 0.11% | 15,800 | 0% | 0% | $97,328 |
| MERCER GLOBAL ADVISORS INC /ADV | 0.09% | 12,775 | 0% | $78,694 | |
| Cambridge Investment Research Advisors, Inc. | 0.09% | 12,252 | 0% | 0% | $75,000 |
| Vanguard Global Advisers, LLC | 0.02% | 2,093 | 0% | 0% | $12,893 |
| BARCLAYS PLC | 0% | 13 | 0% | $80 | |
| JPMORGAN CHASE & CO | 0% | 11 | 0% | 0% | $71 |
| Cassaday & Co Wealth Management LLC | 0% | 10 | 0% | 0% | $62 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
44
Latest
Q2 2026
Rows shown
1-25 of 44
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 5,889,252 | $36,276,009 | +$976,681 | $6.16 | 27 |
| 2026 Q1 | 5,732,288 | $32,958,797 | -$157,299 | $5.75 | 24 |
| 2025 Q4 | 5,750,673 | $39,735,823 | +$624,113 | $6.91 | 26 |
| 2025 Q3 | 5,663,057 | $36,665,391 | -$761,415 | $6.48 | 26 |
| 2025 Q2 | 5,772,731 | $42,541,525 | -$1,253,103 | $7.37 | 29 |
| 2025 Q1 | 5,917,321 | $51,360,014 | +$1,723,264 | $8.68 | 33 |
| 2024 Q4 | 5,718,824 | $49,008,702 | -$371,113 | $8.57 | 24 |
| 2024 Q3 | 5,783,612 | $28,164,672 | +$38,335 | $4.87 | 21 |
| 2024 Q2 | 5,774,158 | $29,850,843 | +$747,882 | $5.17 | 23 |
| 2024 Q1 | 5,633,547 | $27,601,085 | +$42,514 | $4.90 | 24 |
| 2023 Q4 | 5,612,282 | $31,482,391 | -$753,086 | $5.62 | 23 |
| 2023 Q3 | 5,738,643 | $35,637,624 | -$450,468 | $6.21 | 28 |
| 2023 Q2 | 5,810,614 | $37,033,240 | -$275,967 | $6.38 | 27 |
| 2023 Q1 | 5,860,555 | $23,555,996 | -$669,606 | $4.02 | 29 |
| 2022 Q4 | 6,003,532 | $27,075,368 | -$820,131 | $4.51 | 27 |
| 2022 Q3 | 6,237,577 | $46,781,000 | -$101,195 | $7.50 | 27 |
| 2022 Q2 | 6,220,826 | $49,800,000 | +$418,571 | $8.00 | 27 |
| 2022 Q1 | 6,195,380 | $50,369,000 | -$90,258 | $8.13 | 27 |
| 2021 Q4 | 6,206,609 | $51,745,000 | -$921,951 | $8.35 | 29 |
| 2021 Q3 | 6,278,256 | $64,114,459 | -$3,861,348 | $10.21 | 33 |
| 2021 Q2 | 6,655,344 | $68,450,153 | -$6,271,556 | $10.28 | 36 |
| 2021 Q1 | 7,201,194 | $81,382,735 | +$856,252 | $11.30 | 44 |
| 2020 Q4 | 7,131,440 | $76,929,434 | +$1,001,410 | $10.79 | 46 |
| 2020 Q3 | 7,084,905 | $65,541,431 | +$877,249 | $9.25 | 45 |
| 2020 Q2 | 6,969,631 | $66,613,581 | +$4,981,325 | $9.56 | 45 |